Drug Profile
eOD GT8 60mer
Alternative Names: eOD-GT8 60merLatest Information Update: 27 May 2022
Price :
$50
*
At a glance
- Originator Fred Hutchinson Cancer Research Center; International AIDS Vaccine Initiative; La Jolla Institute for Allergy & Immunology; The Scripps Research Institute
- Developer International AIDS Vaccine Initiative
- Class AIDS vaccines; Protein vaccines
- Mechanism of Action B cell stimulants; Immunogenetic stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I HIV infections
Most Recent Events
- 27 May 2022 Phase-I development completed in USA (NCT03547245)
- 28 Nov 2021 No recent reports of development identified for phase-I development in HIV-infections(Prevention, In volunteers) in USA
- 13 Aug 2021 International AIDS Vaccine Initiative completes a phase I trial in HIV infections (Prevention, In volunteers) in USA (NCT03547245)